Latest Breaking News On - Human genome sciences - Page 3 : vimarsana.com

NeoImmuneTech Welcomes a New President for its Development and Business

/PRNewswire/ NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, today announces the appointment of.

United kingdomAmerican professional association in life sciencesRegulatory developmentDivision of inflammationDivision of clinical pharmacologyNeoimmunetech incMallinckrodt pharmaceuticalsPrnewswire neoimmunetech incHuman genome sciencesMcgill university montrealVertex pharmaceuticalsSamsung bioepisSenior staff fellowClinical pharmacologyImmune pharmacologyMcgill university

MaxCyte announces new CEO, updates revenue guidance

Cell engineering technology specialist MaxCyte announced a significant chief executive transition on Tuesday and updated its revenue guidance for 2023.

Maher masoudDoug doerflerRichard douglasHuman genome sciencesCategory allCategory market reportCategory company newsCategory news and announcementsCategory aim bulletinCategory tecnologiaCategory market pulse

MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023

Doug Doerfler, President and CEO, to Retire Effective December 31, 2023; will continue to serve as an advisor to MaxCyte Maher Masoud, EVP, Head of Global Business Development and Chief Counsel,.

United kingdomChris welshMary jane elliottDavid deuchlerPanmure gordonEmma earl freddy crossleyDoug doerflerMaher masoudRichard douglasRupert deardenGlen researchMichigan state university college of lawMaxcyte incHead of global business developmentHuman genome sciencesExchange commission

Ceremorphic Life Sciences Demonstrates New Bio-Supercomputing Platform That Can Speed Every Phase of Drug Discovery and Development

Ceremorphic Life Sciences Demonstrates New Bio-Supercomputing Platform That Can Speed Every Phase of Drug Discovery and Development
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

United statesVenkat mattelaWilliam haseltineProfessor at harvard medical schoolHuman genome sciencesCeremorphic incCeremorphic life sciencesDrug discovery summitLife sciencesSilico modelsHarvard medical schoolFounder chairman

Ceremorphic Life Sciences CEO Delivers Keynote at AI Driven Drug Discovery Summit; Demonstrates New Bio-supercomputing Platform that Can Speed Every Phase of Drug Discovery and Development

Ceremorphic Life Sciences CEO Delivers Keynote at AI Driven Drug Discovery Summit; Demonstrates New Bio-supercomputing Platform that Can Speed Every Phase of Drug Discovery and Development
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesVenkat mattelaWilliam haseltineCeremorphic incCeremorphic life sciencesProfessor at harvard medical schoolHuman genome sciencesDrug discovery summitDemonstrates new bio supercomputing platformCan speed every phaseDrug discoveryLife sciencesSilico modelsHarvard medical schoolFounder chairman